Organisation paid for research Program year 2025 Source: CMS Open Payments

Nebraska Methodist Hospital

Neither a doctor nor a teaching hospital

Research payments

$108,332

55 payments

Through program year 2025, Nebraska Methodist Hospital is reported as receiving $108,332 in research payments, across 55 payments.

By program year

4 rows

Year	Kind	Amount	Payments
2025	Research	$70,829	47
2024	Research	$29,800	4
2021	Research	$1,100	1
2020	Research	$6,603	3

Breakdown

Who paid Research payments · program years 2020–2025

GlaxoSmithKline, LLC. $103,169 53 payments
Pfizer Inc. $5,163 2 payments

Studies the money was for Research payments · program years 2020–2025

A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study to Evalua $62,490 37 payments
A Randomized, Multicenter, Double-Blind, Phase 3 Study to Investigate $34,860 13 payments
A Multicenter Phase 3 Randomized Openlabel Study of Bosutinib Versus Imatinib in Adult Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia $5,163 2 payments
1Nspire Study: Investigating 1L Maintenance Niraparib Safety and Patie $3,280 1 payment
A Phase 2, Single-Arm, Open-Label Study to Evaluate the Safety and Eff $2,540 2 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.